The Priority Review

Tag

ARTISTRY-1

1 story

Stories

  1. Clinical trials

    Gilead posts results of ARTISTRY-1 bictegravir/lenacapavir study

    The study, enrolling 689 participants, compared bictegravir/lenacapavir to stable baseline regimens in virologically suppressed people with HIV-1. Results were first posted on ClinicalTrials.gov on October 21, 2026.